Rhythm Pharmaceuticals, Inc.
RYTM
$103.00
$1.611.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -52.90M | -46.63M | -49.50M | -43.29M | -43.68M |
| Total Depreciation and Amortization | 304.00K | 379.00K | 383.00K | 383.00K | 385.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.87M | 18.42M | 16.67M | 13.86M | 13.38M |
| Change in Net Operating Assets | 3.11M | 4.53M | -7.91M | 10.21M | 4.70M |
| Cash from Operations | -26.62M | -23.31M | -40.35M | -18.85M | -25.22M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -246.35M | 54.04M | 24.81M | 21.16M | -90.82M |
| Cash from Investing | -246.35M | 54.04M | 24.81M | 21.16M | -90.82M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 194.87M | 3.44M | 37.11M | 42.14M | 5.83M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.57M | -4.33M | -4.62M | -3.81M | -3.34M |
| Cash from Financing | 189.30M | -889.00K | 32.50M | 38.33M | 2.49M |
| Foreign Exchange rate Adjustments | 304.00K | -279.00K | -2.00K | 977.00K | -603.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 1.00K | -1.00K |
| Net Change in Cash | -83.36M | 29.55M | 16.96M | 41.62M | -114.15M |